Related Experiment Videos
["Critical-illness" polyneuropathy and -myopathy]
F S Leijten1, M A de Letter, A A Op de Coul
1Afd. Klinische Neurofysiologie, Universitair Medisch Centrum Utrecht.
Nederlands Tijdschrift Voor Geneeskunde
|August 10, 2000
Summary
Critical-illness polyneuropathy and myopathy (CIPNM) is a common cause of ICU weakness, affecting 35-80% of ventilated patients. Diagnosis requires electrophysiology or biopsy, and recovery can be lengthy.
Area of Science:
- Neurology
- Intensive Care Medicine
- Pathology
Context:
- Critical-illness polyneuropathy and myopathy (CIPNM) is the most frequent cause of muscle weakness in intensive care units (ICUs).
- CIPNM affects 35-80% of patients requiring prolonged mechanical ventilation.
- It is linked to the broader syndrome of multiple organ dysfunction.
Purpose:
- To outline the characteristics, diagnosis, and implications of critical-illness polyneuropathy and myopathy.
- To highlight the association between CIPNM, critical illness, and specific treatments like corticosteroids.
- To describe the challenges in patient recovery, including ventilation weaning and rehabilitation.
Summary:
- CIPNM involves immune responses, increased vascular permeability, and inflammation, leading to muscle damage.
- Electrophysiological studies and muscle biopsies are often needed for diagnosis.
- Corticosteroid use is a notable factor associated with myopathy.
Impact:
- Understanding CIPNM is crucial for managing critically ill patients and improving outcomes.
- Difficulties in weaning from mechanical ventilation and prolonged rehabilitation are common.
- Early recognition and management strategies may improve patient recovery trajectories.